BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1561309)

  • 41. DNA supercoiling changes and nuclear matrix-associated proteins: possible role in oncogene-mediated radioresistance.
    Malyapa RS; Wright WD; Taylor YC; Roti Roti JL
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):963-73. PubMed ID: 8751405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ras/MEK signaling suppresses Myc-dependent apoptosis in cells transformed by c-myc and activated ras.
    Tsuneoka M; Mekada E
    Oncogene; 2000 Jan; 19(1):115-23. PubMed ID: 10644986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resistance of murine LTA cells to oncogene--mediated progression from tumorigenic to metastatic phenotype.
    Tuck AB; Wilson SM; Chambers AF
    Anticancer Res; 1990; 10(6):1507-14. PubMed ID: 2285224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prolonged cell cycle delay in radioresistant human cell lines transfected with activated ras oncogene and/or simian virus 40 T-antigen.
    Su LN; Little JB
    Radiat Res; 1993 Jan; 133(1):73-9. PubMed ID: 8434116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neoplastic transformation dose response of oncogene-transfected rat embryo cells by gamma rays or 6 MeV alpha particles.
    Ling CC; Weiss H; Strauss A; Endlich B; Sheh Y; Wei JX; Orazem J
    Radiat Res; 1994 Apr; 138(1):79-85. PubMed ID: 8146303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts.
    Bernhard EJ; Kao G; Cox AD; Sebti SM; Hamilton AD; Muschel RJ; McKenna WG
    Cancer Res; 1996 Apr; 56(8):1727-30. PubMed ID: 8620483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes.
    Arends MJ; McGregor AH; Wyllie AH
    Am J Pathol; 1994 May; 144(5):1045-57. PubMed ID: 8178928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes.
    Torigoe T; Sato N; Takashima T; Cho JM; Tsuboi N; Qi WM; Hara I; Wada Y; Takahashi N; Kikuchi K
    J Immunol; 1991 Nov; 147(9):3251-8. PubMed ID: 1919013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-beta.
    Houck KA; Michalopoulos GK; Strom SC
    Oncogene; 1989 Jan; 4(1):19-25. PubMed ID: 2783773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apoptosis induced at different dose rates: implication for the shoulder region of cell survival curves.
    Ling CC; Chen CH; Li WX
    Radiother Oncol; 1994 Aug; 32(2):129-36. PubMed ID: 7972906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes].
    Niimi S; Yokoyama S; Terashima Y; Saijo N
    Hum Cell; 1991 Mar; 4(1):33-7. PubMed ID: 1888702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of the H-ras oncogene in radiation resistance and metastasis.
    McKenna WG; Weiss MC; Bakanauskas VJ; Sandler H; Kelsten ML; Biaglow J; Tuttle SW; Endlich B; Ling CC; Muschel RJ
    Int J Radiat Oncol Biol Phys; 1990 Apr; 18(4):849-59. PubMed ID: 2182580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radioresistance induced in rat embryo cells by transfection with the oncogenes H-ras plus v-myc is cell cycle dependent and maximal during S and G2.
    Cheong N; Wang Y; Iliakis G
    Int J Radiat Biol; 1993 May; 63(5):623-9. PubMed ID: 8099108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Some ras-transformed cells have increased radiosensitivity and decreased repair of sublethal radiation damage.
    Harris JF; Chambers AF; Tam AS
    Somat Cell Mol Genet; 1990 Jan; 16(1):39-48. PubMed ID: 2408158
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on the influence of the presence of an activated ras oncogene on the in vitro radiosensitivity of human mammary epithelial cells.
    Alapetite C; Baroche C; Remvikos Y; Goubin G; Moustacchi E
    Int J Radiat Biol; 1991 Feb; 59(2):385-96. PubMed ID: 1671689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between intrinsic radiation sensitivity and metastatic potential.
    Lewis AM; Su M; Doty J; Chen Y; Pardo FS
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):103-10. PubMed ID: 12118537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes.
    Niimi S; Nakagawa K; Yokota J; Tsunokawa Y; Nishio K; Terashima Y; Shibuya M; Terada M; Saijo N
    Br J Cancer; 1991 Feb; 63(2):237-41. PubMed ID: 1997100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro radiosensitivity of human leukemia cell lines.
    Weichselbaum RR; Greenberger JS; Schmidt A; Karpas A; Moloney WC; Little JB
    Radiology; 1981 May; 139(2):485-7. PubMed ID: 6939019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistent inhibition of DNA synthesis after radiation exposure in four clones obtained from rat embryo fibroblasts by transfection with the oncogenes H-ras plus v-myc.
    Wang X; Iliakis G
    Int J Radiat Biol; 1993 Aug; 64(2):165-8. PubMed ID: 8103539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The radiosensitivity of human keratinocytes: influence of activated c-H-ras oncogene expression and tumorigenicity.
    Mendonca MS; Boukamp P; Stanbridge EJ; Redpath JL
    Int J Radiat Biol; 1991 May; 59(5):1195-206. PubMed ID: 1675238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.